The antiviral medicine remdesivir from Gilead Sciences failed to speed the improvement of patients in China with Covid-19 or prevent them from dying.
Watching
Latest
-
Wegman uses biometric surveillance on shoppers, raising privacy concerns
-
UK ordered agents to find UFO tech in bombshell 1990s secret files shocker | New York Post
-
Private equity barons target savers in hunt for ‘the perfect bailout’
-
Giant structure discovered deep beneath Bermuda is unlike anything else on Earth | Live Science